News | May 08, 2026
Sanofi India partners with NHM MP to expand NCD, rare disease services
The partnership will focus on diabetes and NCD awareness, rare disease screening, and deployment of mobile medical units
The partnership will focus on diabetes and NCD awareness, rare disease screening, and deployment of mobile medical units
Rahul Bhatnagar succeeds Aditya Narayan, who completed a decade-long distinguished tenure
Domestic sales increased 15.5%, supported by the relaunch of previously recalled products in the market
Deal includes 13 branded generic products across 55+ countries; acquisition expected to strengthen global anti-infective portfolio and expand regulated market presence
The aim is to bolster healthcare delivery in a region increasingly burdened by chronic disease
He brings extensive cross-functional expertise built through leadership roles
For the fourth quarter, revenue surged 47% year-on-year to Rs. 2,510 million, driven by a 23% rise in domestic sales and a 9.3x jump in export sales
Backed by a multi-hundred-million-dollar investment, the expansion underscores Sanofi’s long-term commitment to India’s thriving life sciences ecosystem
Duvakitug was well tolerated and safety was consistent with the induction study
Garijo will be the first woman to lead Sanofi in its history
Subscribe To Our Newsletter & Stay Updated
